Royalty Pharma (RPRX) Director Bonnie Bassler Receives Award

What Happened
Bonnie L. Bassler, a director of Royalty Pharma plc (RPRX), was granted 642 Class A ordinary shares on 2026-09-30. The filing reports the shares were valued at $58.41 each for a reported total of $37,496. This was an equity award issued as director compensation (an issuance, not a market purchase).

Key Details

• Transaction date and price: 2026-09-30; 642 shares at $58.41 per share.
• Reported value: $37,496 (as stated in the filing).
• Transaction code: A — Award/Grant (shares issued to reporting person).
• Footnote: Issued under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500 (filing footnote F1).
• Shares owned after transaction: not disclosed in the supplied filing data.
• Filing timeliness: Reported and filed with the SEC on 2026-09-30 (same-day filing).

Context
Director equity awards in lieu of cash retainers are routine compensation and do not necessarily indicate insider trading sentiment. This was an issuance of shares as pay — not a buy or sale in the open market.